Lexicon Pharmaceuticals Inc (LXRX)
1.845
-0.10
(-4.90%)
USD |
NASDAQ |
May 16, 16:00
1.845
0.00 (0.00%)
After-Hours: 18:23
Lexicon Pharmaceuticals Free Cash Flow: -185.41M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -185.41M |
December 31, 2023 | -162.37M |
September 30, 2023 | -134.63M |
June 30, 2023 | -112.38M |
March 31, 2023 | -98.54M |
December 31, 2022 | -90.18M |
September 30, 2022 | -90.21M |
June 30, 2022 | -88.13M |
March 31, 2022 | -86.54M |
December 31, 2021 | -88.24M |
September 30, 2021 | -99.68M |
June 30, 2021 | -122.73M |
March 31, 2021 | -146.20M |
December 31, 2020 | -143.06M |
September 30, 2020 | -133.13M |
June 30, 2020 | 97.98M |
March 31, 2020 | 117.37M |
December 31, 2019 | 113.74M |
September 30, 2019 | 110.94M |
June 30, 2019 | -101.94M |
March 31, 2019 | -127.58M |
December 31, 2018 | -148.70M |
September 30, 2018 | -155.25M |
June 30, 2018 | -167.09M |
March 31, 2018 | -146.85M |
Date | Value |
---|---|
December 31, 2017 | -185.62M |
September 30, 2017 | -200.85M |
June 30, 2017 | -202.06M |
March 31, 2017 | -217.65M |
December 31, 2016 | -175.86M |
September 30, 2016 | 138.76M |
June 30, 2016 | 148.32M |
March 31, 2016 | 163.57M |
December 31, 2015 | 183.87M |
September 30, 2015 | -86.30M |
June 30, 2015 | -81.83M |
March 31, 2015 | -68.86M |
December 31, 2014 | -75.70M |
September 30, 2014 | -93.17M |
June 30, 2014 | -96.17M |
March 31, 2014 | -98.04M |
December 31, 2013 | -92.80M |
September 30, 2013 | -91.39M |
June 30, 2013 | -92.30M |
March 31, 2013 | -92.83M |
December 31, 2012 | -94.95M |
September 30, 2012 | -97.11M |
June 30, 2012 | -92.39M |
March 31, 2012 | -94.33M |
December 31, 2011 | -89.14M |
Free Cash Flow Range, Past 5 Years
-185.41M
Minimum
Mar 2024
117.37M
Maximum
Mar 2020
-72.17M
Average
-99.11M
Median
Free Cash Flow Benchmarks
Windtree Therapeutics Inc | -13.45M |
AIM ImmunoTech Inc | -21.85M |
Perspective Therapeutics Inc | -37.98M |
Protalix BioTherapeutics Inc | 4.369M |
Armata Pharmaceuticals Inc | -46.82M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -55.13M |
Cash from Investing (Quarterly) | -110.22M |
Cash from Financing (Quarterly) | 239.38M |
Free Cash Flow Per Share (Quarterly) | -0.2247 |
Free Cash Flow to Equity (Quarterly) | -55.50M |
Free Cash Flow Yield | -42.75% |